Market Cap : 229.49 B | Enterprise Value : 251.05 B | PE Ratio : 13.86 | PB Ratio : 5.32 |
---|
NYSE:MRK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:MRK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Merck's enterprise value is $251,050 Mil. Merck's Revenue for the trailing twelve months (TTM) ended in Jun. 2022 was $57,169 Mil. Therefore, Merck's EV-to-Revenue for today is 4.39.
The historical rank and industry rank for Merck's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of Merck was 6.28. The lowest was 2.02. And the median was 4.28.
MRK's EV-to-Revenue is ranked worse thanThe reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2022-08-16), Merck's stock price is $90.59. Merck's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 was $22.53. Therefore, Merck's PS Ratio for today is 4.02.
The historical data trend for Merck's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Merck's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Merck's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Merck's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Merck's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 251050.154 | / | 57169 | |
= | 4.39 |
Merck's current Enterprise Value is $251,050 Mil.
Merck's Revenue for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $57,169 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Merck's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 90.59 | / | 22.527 | |
= | 4.02 |
Merck's share price for today is $90.59.
Merck's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.53.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Merck's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Baker Douglas M Jr | director | 370 WBASHA ST NORTH ST PAUL MN 55102 |
Oosthuizen Johannes Jacobus | officer: SVP, U.S. Market | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Garay Arpa | officer: SVP Human Health Global Mktg. | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Downing Cristal N | officer: Chief Comm. & Public Afrs Ofcr | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Klobuchar Michael A | officer: EVP - Chief Strategy Officer | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Lecointe-cephas Lisa | officer: SVP Chief Ethics & Com Officer | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Litchfield Caroline | officer: EVP & CFO | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Mayo Stephen | director | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Li Dean Y | officer: Executive VP & President, MRL | 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Williams David Michael | officer: EVP,Chief Info&Digital Officer | MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Lavizzo-mourey Risa J | director | GENERAL ELECTRIC COMPANY 5 NECCO STREET BOSTON MA 02210 |
Seidman Christine E | director | MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Warden Kathy J | director | 2980 FAIRVIEW PARK DRIVE FALLS CHURCH VA 22042 |
Craig Pamela | director | C/O ACCENTURE 161 N CLARK STREET CHICAGO IL 60601 |
Brun Leslie A | director | 435 DEVON PARK DRIVE 700 BUILDING WAYNE PA 19087 |
From GuruFocus
Other Sources
By Zacks 2022-03-25
By Zacks 2022-03-28
By Zacks 2022-04-05
By Zacks 2022-03-29
By tipranks.com 2022-03-28
By tipranks.com 2022-03-17
By Zacks 2022-03-23
By Zacks 2022-04-05
By Zacks 2022-03-28
By Zacks 2022-03-22
By Zacks 2022-03-22
By Zacks 2022-03-25
By Zacks 2022-03-31